Special issues in genetic testing for Alzheimer disease

Area of Science:

• Neurogenetics
• Medical Ethics
• Genetic Counseling

Background:

• Genetic testing for Alzheimer disease (AD) presents unique ethical and practical challenges.
• Diagnostic genetic testing in dementia patients yields predictive information for relatives.

Purpose of the Study:

• To address the complexities of genetic testing for Alzheimer disease.
• To examine the implications of predictive genetic information for family members.
• To discuss the ethical considerations of reinterpreting existing genetic test results.

Main Methods:

• Review of current practices in genetic testing for Alzheimer disease.
• Analysis of ethical frameworks for genetic information disclosure.
• Case study of apolipoprotein E (APOE) allele testing for cardiovascular risk and its implications for AD risk.

Main Results:

• Genetic testing for AD in patients necessitates careful consideration of information disclosure to family members.
• The apolipoprotein E (APOE) gene, previously tested for cardiovascular risk, now has implications for AD risk.
• Re-evaluation of genetic test results for new disease associations requires attention.

Conclusions:

• Ethical guidelines are needed for disclosing predictive genetic information related to Alzheimer disease.
• Clear protocols must be established for managing the implications of newly discovered disease associations for existing genetic tests.
• Informed consent and patient autonomy are paramount in genetic testing and result interpretation.